A disagreement between the technical staff and the board is part of the institutional design of Brazil’s securities regulator ...
CEL-SCI shares are trading higher by 18.6% during Wednesday's session. The company received positive feedback from the FDA regarding their cancer immunotherapy. 9 Out of the Last 10 Summers this ...
Tracey Forfa, a 30-year veteran of the Food and Drug Administration, will become the new director of FDA’s Center for Veterinary Medicine. She has been CVM’s acting director since December, when ...
CEL-SCI Corporation shares are trading lower by 13.9% Friday morning. The company priced an offering of 3.875 million shares. Historic Summer Setup: 3 "Power Patterns" Triggering in the next 75 Days - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results